Börje Darpö

ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs

Philip T. Sager, T Nebout, Börje Darpö · Drug Information Journal · 2005 · 383 citations

Electrophysiological Evaluation, Cardiovascular Disease, New Regulatory Guidance +10

Clinical Evaluation of QT/QTc Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs: The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 Guideline

Börje Darpö, T Nebout, Philip T. Sager · The Journal of Clinical Pharmacology · 2006 · 316 citations

Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications

Jan Hedner, Börje Darpö, H. Ejnell et al. · European Respiratory Journal · 1995 · 299 citations · Full text

Asthma, Obstructive Sleep Apnoea, Heart Failure +18

Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes

Börje Darpö · European Heart Journal Supplements · 2001 · 203 citations

Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase

Börje Darpö, Charles Benson, Corina Dota et al. · Clinical Pharmacology & Therapeutics · 2015 · 176 citations · Full text